Your browser is no longer supported. Please, upgrade your browser. Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
ABBV [NYSE]
AbbVie Inc.
IndexS&P 500 P/E29.46 EPS (ttm)2.31 Insider Own0.08% Shs Outstand1.59B Perf Week3.04%
Market Cap108.45B Forward P/E16.11 EPS next Y4.22 Insider Trans12.83% Shs Float1.57B Perf Month12.51%
Income3.71B PEG2.34 EPS next Q0.86 Inst Own89.50% Short Float1.88% Perf Quarter23.10%
Sales19.62B P/S5.53 EPS this Y-23.10% Inst Trans10.82% Short Ratio2.24 Perf Half Y27.86%
Book/sh2.91 P/B23.39 EPS next Y27.73% ROA12.90% Target Price67.36 Perf Year45.12%
Cash/sh4.85 P/C14.03 EPS next 5Y12.58% ROE77.90% 52W Range44.82 - 68.06 Perf YTD33.03%
Dividend1.96 P/FCF50.82 EPS past 5Y0.00% ROI23.20% 52W High0.00% Beta-
Dividend %2.88% Quick Ratio2.50 Sales past 5Y- Gross Margin76.90% 52W Low51.84% ATR1.31
Employees25000 Current Ratio2.60 Sales Q/Q7.80% Oper. Margin29.00% RSI (14)72.32 Volatility1.52% 1.86%
OptionableYes Debt/Eq3.18 EPS Q/Q-48.30% Profit Margin18.90% Rel Volume0.57 Prev Close67.78
ShortableYes LT Debt/Eq3.11 EarningsOct 31 BMO Payout70.40% Avg Volume13.19M Price68.06
Recom2.10 SMA206.83% SMA5013.98% SMA20025.70% Volume7,550,800 Change0.41%
Nov-26-14Reiterated Argus Buy $65 → $85
Nov-14-14Initiated Deutsche Bank Buy $80
Jul-28-14Upgrade UBS Neutral → Buy $57 → $67
Jun-24-14Reiterated Argus Buy $59 → $65
Jan-06-14Reiterated UBS Neutral $46 → $56
Oct-29-13Reiterated Argus Buy $52 → $59
Aug-12-13Initiated Argus Buy $52
May-15-13Reiterated R. F. Lafferty Buy $47.90 → $61
Apr-29-13Reiterated Barclays Equal Weight $41 → $44
Apr-15-13Reiterated Barclays Equal Weight $37 → $41
Nov-24-14 06:00PM  AbbVie's HCV Cocktail Treatment Closer to EU Approval Zacks
05:54PM  Inversions Become Political Hazard as Stryker Weighs Deal Bloomberg
04:48PM  Most Sectors Represent in Today's Lg Cap All-Time Highs... Yahoo Finance Blogs
10:54AM  Hedge funds playing buy-and-hold, and losing at CNBC
Nov-21-14 10:02PM  John Paulson's Top 5 New Holdings for Q3 Gurufocus
04:00PM  Amgen and AbbVie Strengthen Manufacturing Facilities in Asia Zacks
08:19AM  Drug Name or Pokemon? It's Getting Harder to Tell the Difference Yahoo Finance Blogs
08:00AM  CHMP Grants Positive Opinions of AbbVie's VIEKIRAX (ombitasvir/paritaprevir/ritonavir) + EXVIERA (dasabuvir) for the Treatment of Chronic Hepatitis C in Europe PR Newswire
07:20AM  Europe gives green light to AbbVie hepatitis C medicine, others Reuters
Nov-20-14 09:00PM  AbbVie Acquires Manufacturing Facility in Singapore; Further Expands Capabilities in Asia PR Newswire
11:50AM  Billionaire ETF Index Adds Facebook, Dumps Netflix, Others ETF Trends
Nov-19-14 03:20PM  AstraZeneca Targets More than $45B in Revenues in 2023 Zacks
02:50PM  Pharma Industry Outlook: M&A, Licensing Abound Zacks
12:25PM  'More Biotechy?' Shire to Move US HQ and 500 Jobs to Greater Boston at The Wall Street Journal
Nov-18-14 04:41PM  Health Care dominates the Lg Cap All-Time Highs today... Yahoo Finance Blogs
03:44PM  Novartis Presents Data on Heart Failure Candidate LCZ696 Zacks
Nov-17-14 06:27PM  Will IPOs WhiteWave, Enanta Surpass Buy Points? at Investor's Business Daily
06:27PM  Five Ethical Drugmakers Keep Leadership Positions at Investor's Business Daily
05:34PM  Ownership Roundup: Buffett and the Hedge Funds at 3Q at Barrons.com
09:00AM  AbbVie to Present Data on Investigational Oncology Compounds at the 56th American Society of Hematology Annual Meeting PR Newswire
07:00AM  AbbVie to Present at Jefferies 2014 Global Healthcare Conference PR Newswire
Nov-14-14 06:46PM  Paulson takes stake in Abbvie, adds to Shire holdings at MarketWatch
04:48PM  AbbVie Presents Results from Study of ABT-414 in Patients with Glioblastoma Multiforme at the 19th Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology PR Newswire
01:04PM  ABBVIE INC. Financials EDGAR Online Financials
12:22PM  Coverage initiated on AbbVie by Deutsche Bank Briefing.com
Nov-13-14 03:48PM  Can Gilead Recover from 3Q? at Barrons.com
09:15AM  4 Top Pharmaceutical Companies Helping Combat Hepatitis C Near Epidemic at 24/7 Wall St.
09:00AM  AbbVie's Leadership in Immunology Featured at 2014 American College of Rheumatology Annual Meeting with New Data on Investigational Medicines and HUMIRA® (adalimumab) PR Newswire
07:36AM  The Zacks Analyst Blog Highlights: Dendreon, Amgen, Regeneron, AbbVie and Gilead Zacks
Nov-12-14 12:51PM  European Ombudsman Questions EMA Redactions of AbbVie Trial Data at The Wall Street Journal
Nov-11-14 12:25PM  Will Time Warner-Comcast Deal Survive Net Neutrality? at Barrons.com
10:23AM  AbbVie, Enanta drug shows potential in hep C genotype 4 patients Reuters
09:00AM  AbbVie to Present Results from Studies in Chronic Hepatitis C Patients with HIV-1 Co-Infection (TURQUOISE-I) and Liver Transplant Recipients (CORAL-I) at The Liver Meeting® 2014 PR Newswire
09:00AM  AbbVie Hepatitis C Drug Cures 97% in Transplant Patients Study at Bloomberg
08:31AM  Stock Market News for November 11, 2014 Zacks
08:00AM  AbbVie to Present Results from Phase 2 PEARL-I Study in Genotype 4 Chronic Hepatitis C Patients at The Liver Meeting® 2014 PR Newswire
Nov-10-14 04:46PM  Shire CEO Looks Ahead To Independent Future at Investor's Business Daily
01:20PM  Paulson Advantage fund down 24 pct for year after tough October Reuters
12:39PM  Merck, Dendreon miss out on health-care rally at MarketWatch
11:14AM  Merck Down On Hepatitis C Data; Gilead Rises at Investor's Business Daily
Nov-09-14 06:23PM  Merck's Shortened Hep C Regimens Fall Short of Cure-Rate Goal at TheStreet
Nov-07-14 04:10PM  ABBVIE INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
11:50AM  One Factor Driving AbbVie (ABBV) Stock Down Today at TheStreet
08:42AM  [video]Analysts' Actions: AbbVie, HollyFrontier, NRG Energy, PetSmart TheStreet
Nov-06-14 09:52AM  Top 2 MedTech Stocks, Poised to Gain on Earnings this Season Zacks
09:25AM  How Billionaires Stack Up in Bill Ackman's Big Allergan Bid at TheStreet
07:46AM  AstraZeneca touts independence as Nexium drug keeps on giving Reuters
Nov-05-14 01:57PM  Elliott Associates may sue AbbVie over scuttled deal Reuters
12:54PM  3 Biotech Stocks for Earnings Beats this Season Zacks
11:52AM  Elliott Associates says mulls lawsuit against AbbVie - letter Reuters
08:02AM  ABBVIE (ABBV) SHAREHOLDER ALERT Andrews & Springer LLC Is Investigating AbbVie Inc. For Potential Securities Fraud and Breach of Fiduciary Duty Business Wire
08:00AM  AbbVie to Present at Credit Suisse 2014 Healthcare Conference PR Newswire
Nov-04-14 05:08AM  AbbVie (ABBV) Shares March Higher, Can It Continue? Zacks
Nov-03-14 07:05AM  Myriad and AbbVie Sign Expanded Agreement for Tumor BRACAnalysis CDx(TM) GlobeNewswire
06:35AM  Investors see green in Ireland CNBC
01:03AM  [$$] AbbVie Reports Higher Sales, Outlook at The Wall Street Journal
Oct-31-14 04:35PM  Tricky October Ends With A Treat For Stocks at Forbes
04:24PM  The rally that keeps on giving! Yahoo Finance Blogs
02:25PM  AbbVie Beats Q3 Earnings Estimates, Raises Guidance at Investor's Business Daily
01:23PM  AbbVie (ABBV) Earnings Report: Q3 2014 Conference Call Transcript at TheStreet
12:08PM  [$$] AbbVie Boosts Earnings Guidance at The Wall Street Journal
11:56AM  Investors Could Triple Their Investments in AbbVie Gurufocus
11:54AM  AbbVie CEO: Unlikely to Pursue Another $50 Billion Deal at The Wall Street Journal
11:22AM  AbbVie says strong results lessen need for big deal Reuters
11:17AM  Mylan Rises On Q3 Earnings Beat, Affirms Abbott Deal at Investor's Business Daily
10:20AM  AbbVie Q3 Earnings Top on Humira Sales, Boosts Outlook Zacks
09:30AM  AbbVie hikes forecast, tops Street expectations AP
09:00AM  AbbVie Inc Earnings Call scheduled for 9:00 am ET today CCBN
08:08AM  AbbVie sales blow past forecasts, fueled by Humira Reuters
08:01AM  AbbVie Raises Earnings Guidance After Humira Sales Surge at Bloomberg
08:00AM  AbbVie shares up 2% as profit, sales beat estimates at MarketWatch
07:57AM  AbbVie beats 3Q profit forecasts AP
07:56AM  ABBVIE INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
07:49AM  AbbVie Reports Third-Quarter 2014 Financial Results PR Newswire
07:07AM  Q3 2014 AbbVie Inc Earnings Release - Before Market Open CCBN
Oct-30-14 03:06PM  What to Watch in the Day Ahead - Friday, Oct. 31 Reuters
Oct-29-14 02:28PM  Will AbbVie (ABBV) Disappoint in this Earnings Season? Zacks
01:59PM  Express Scripts says AbbVie drug could displace Sovaldi on formulary Reuters
09:54AM  U.S. law firm says investigating AbbVie over collapsed Shire deal Reuters
09:51AM  The Zacks Analyst Blog Highlights: AbbVie, Mylan, Abbott Laboratories, Actavis and Mallinckrodt Zacks
08:38AM  If You Purchased Shire plc American Depository Receipts ("ADRs") During The Period Of June 20, 2014 And October 14, 2014 And Lost Money, Gardy & Notis, LLP Encourages You To Contact The Law Firm PR Newswire
Oct-28-14 03:10PM  Pfizer Q3 Earnings Top Estimates Despite Generic Pressure Zacks
02:18PM  Amgen Refuses To Split, But Plans Hearten Investors at Investor's Business Daily
11:46AM  Receptos Soars After Lead Drug Racks Up Another Win at Investor's Business Daily
11:41AM  5 dividend aristocrat stocks set to boost earnings up to 77% at MarketWatch
07:22AM  Pfizer beats forecasts on demand for cancer drugs at CNBC
Oct-27-14 05:04PM  Today's Market Thorns, Roses, and All Time Highs... Yahoo Finance Blogs
12:17PM  Video: Allergan Lifts Views; Valeant Suggests Higher Bid at Investor's Business Daily
09:50AM  Shire (SHPG) Gains on Q3 Earnings Beat, Ups Guidance Zacks
12:45AM  [$$] Shire Raises Earnings Guidance After Record Sales Growth at The Wall Street Journal
Oct-24-14 10:57PM  [$$] Payout Bonanza at Barrons.com
06:01PM  Shire EPS And Sales Growth Accelerate Investor's Business Daily
05:32PM  Shire's Got Big Plans for AbbVie's Breakup Fee at The Wall Street Journal
03:24PM  Shire CEO on AbbVie collapse & inversions CNBC
12:52PM  Chiquita turns to Brazilian group after Fyffes deal collapses Reuters
11:12AM  Shire EPS Growth Accelerates, Stock Continues Rebound at Investor's Business Daily
07:18AM  Shire Raises Forecast Again After Earnings Beat Estimates at Bloomberg
05:39AM  Goldman's Hedge Fund Selector Highlights 'Extremely Difficult' Period at The Wall Street Journal
Oct-23-14 04:21PM  Brazil suitors increase bid for Chiquita at USA TODAY
08:00AM  AbbVie Named a Top Employer in Science Magazine's Annual Survey for Second Consecutive Year PR Newswire
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. Its products include adult and pediatric pharmaceuticals, such as HUMIRA, a biologic therapy administered as a subcutaneous injection to treat autoimmune diseases; Synthroid to treat hypothyroidism; AndroGel, a daily testosterone replacement therapy; Creon, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Kaletra, a prescription anti-HIV-1 medicine used with other anti-HIV-1 medications to increase the chance of treatment response in people with HIV-1; Norvir , a protease inhibitor indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection; and Lupron, a product for the palliative treatment of advanced prostate cancer. The company also offers TriCor and TRILIPIX, which are fibric acid derivatives that are indicated as adjuncts to diet to reduce total cholesterol, LDL cholesterol, and triglyceride levels; Niaspan, an extended release form of niacin that is indicated as an adjunct to diet to reduce total cholesterol, LDL cholesterol, and triglyceride levels, as well as to increase HDL cholesterol levels; Synagis, which protects at-risk infants from severe respiratory disease or respiratory syncytial virus; Sevoflurane, an anesthesia product for human use; Duodopa, a levodopa-carbidopa intestinal gel used to treat advanced Parkinson's disease; and Zemplar used for the prevention and treatment of secondary hyperparathyroidism. It sells its products to wholesalers, distributors, government agencies, health care facilities, specialty pharmacies, and independent retailers from its distribution centers and public warehouses. It has a strategic collaboration with Infinity Pharmaceuticals, Inc.; and a research and development collaboration with California Life Sciences LLC. AbbVie Inc. was incorporated in 2012 and is based in North Chicago, Illinois. As of January 01, 2013, AbbVie Inc. operates independently of Abbott Laboratories.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HURWICH THOMAS A.VP, ControllerNov 06Option Exercise24.0710,000240,73171,448Nov 07 05:57 PM
GONZALEZ RICHARD AChairman of the Board and CEOMar 04Sale51.204,799245,706395,403Mar 04 05:13 PM
Schumacher Laura JEVP, Bus.Dev.,Ext.Aff.&GCMar 03Sale50.034,143207,284273,585Mar 04 05:18 PM
SALEKI-GERHARDT AZITASVP, OperationsMar 03Sale50.252,443122,76085,828Mar 04 05:17 PM
CHASE WILLIAM JEVP, Chief Financial OfficerMar 03Sale50.223,948198,259180,068Mar 04 05:12 PM
ALBAN CARLOSEVP, Commercial OperationsMar 03Sale50.092,882144,356205,138Mar 04 05:10 PM
HURWICH THOMAS A.VP, ControllerFeb 18Option Exercise44.939,138410,57061,016Feb 19 05:33 PM
Schumacher Laura JEVP, Bus.Dev.,Ext.Aff.&GCFeb 18Option Exercise43.218,928385,779256,224Feb 19 05:35 PM
RICHMOND TIMOTHY J.SVP, Human ResourcesFeb 18Sale51.2346523,82283,913Feb 19 05:35 PM
SALEKI-GERHARDT AZITASVP, OperationsFeb 10Option Exercise45.061,46666,05865,856Feb 12 04:49 PM
SALEKI-GERHARDT AZITASVP, OperationsFeb 05Sale47.8468732,86664,390Feb 07 05:08 PM
RICHMOND TIMOTHY J.SVP, Human ResourcesFeb 05Sale47.781,46069,76385,470Feb 07 05:08 PM